Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Debt Ratio (2016 - 2019)

Historic Debt Ratio for Fate Therapeutics (FATE) over the last 8 years, with Q3 2019 value amounting to 0.04.

  • Fate Therapeutics' Debt Ratio fell 3940.49% to 0.04 in Q3 2019 from the same period last year, while for Sep 2019 it was 0.04, marking a year-over-year decrease of 3940.49%. This contributed to the annual value of 0.07 for FY2018, which is 5032.09% down from last year.
  • As of Q3 2019, Fate Therapeutics' Debt Ratio stood at 0.04, which was down 3940.49% from 0.07 recorded in Q2 2019.
  • Over the past 5 years, Fate Therapeutics' Debt Ratio peaked at 0.44 during Q1 2015, and registered a low of 0.04 during Q3 2019.
  • Moreover, its 5-year median value for Debt Ratio was 0.16 (2018), whereas its average is 0.18.
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 167023.44% in 2015, then tumbled by 6968.57% in 2017.
  • Fate Therapeutics' Debt Ratio (Quarter) stood at 0.27 in 2015, then plummeted by 58.42% to 0.11 in 2016, then grew by 25.07% to 0.14 in 2017, then plummeted by 50.32% to 0.07 in 2018, then tumbled by 41.39% to 0.04 in 2019.
  • Its Debt Ratio was 0.04 in Q3 2019, compared to 0.07 in Q2 2019 and 0.07 in Q1 2019.